93 related articles for article (PubMed ID: 8800057)
1. Plasma platelet-derived growth factor: preliminary study of a potential marker in head and neck cancer.
Gleich LL; Srivastava L; Gluckman JL
Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):710-2. PubMed ID: 8800057
[TBL] [Abstract][Full Text] [Related]
2. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: correlation with stage and rate of progression.
Ariad S; Seymour L; Bezwoda WR
Breast Cancer Res Treat; 1991 Dec; 20(1):11-7. PubMed ID: 1667486
[TBL] [Abstract][Full Text] [Related]
4. Elevated arginine vasopressin levels in squamous cell cancer of the head and neck.
Talmi YP; Wolf GT; Hoffman HT; Krause CJ
Laryngoscope; 1996 Mar; 106(3 Pt 1):317-21. PubMed ID: 8614196
[TBL] [Abstract][Full Text] [Related]
5. Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.
Kurimoto M; Nishijima M; Hirashima Y; Endo S; Takaku A
Acta Neurochir (Wien); 1995; 137(3-4):182-7. PubMed ID: 8789659
[TBL] [Abstract][Full Text] [Related]
6. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
8. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of imatinib and carboplatin on VEGF, PDGF and PDGF-Rα/ß expression in squamous cell carcinoma of the head and neck in vitro.
Schultz JD; Rotunno S; Riedel F; Anders C; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Int J Oncol; 2011 Apr; 38(4):1001-12. PubMed ID: 21249316
[TBL] [Abstract][Full Text] [Related]
11. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
[TBL] [Abstract][Full Text] [Related]
12. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
13. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH
Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769
[TBL] [Abstract][Full Text] [Related]
15. Serum PDGF-AB in pleural mesothelioma.
Filiberti R; Marroni P; Neri M; Ardizzoni A; Betta PG; Cafferata MA; Canessa PA; Puntoni R; Ivaldi GP; Paganuzzi M
Tumour Biol; 2005; 26(5):221-6. PubMed ID: 16103743
[TBL] [Abstract][Full Text] [Related]
16. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma platelet-derived growth factor B-chain levels in cancer patients.
Leitzel K; Bryce W; Tomita J; Manderino G; Tribby I; Thomason A; Billingsley M; Podczaski E; Harvey H; Bartholomew M
Cancer Res; 1991 Aug; 51(16):4149-54. PubMed ID: 1868437
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor-derived DNA may permit the early diagnosis of head and neck squamous cell carcinomas.
Nunes DN; Kowalski LP; Simpson AJ
Int J Cancer; 2001 Apr; 92(2):214-9. PubMed ID: 11291048
[TBL] [Abstract][Full Text] [Related]
19. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
Eibling DE; Johnson JT; Wagner RL; Su S
Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
